Therapeutic properties and tolerance of procaine and phenazone containing ear drops in infants and very young children

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 10, 2009, Pages 504-512

  Adam, Dieter ^a   Federspil, Pierre ^b   Lukes, Martin ^c   Petrowicz, Otto ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c ENT Practice   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute otitis media; Anesthetic ear drops; CAS 51 05 8; CAS 60 80 0; Children; Otalgan ; Phenazone; Procaine hydrochloride

Indexed keywords

CAS 51 05 8; CAS 60 80 0; EAR DROPS; OTALGAN; PHENAZONE; PROCAINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ACUTE OTITIS MEDIA; ADVERSE OUTCOME; AGED; ANALGESIA; ARTICLE; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; EXTERNAL AUDITORY CANAL; EXTERNAL OTITIS; FEMALE; HUMAN; INFANT; INFLAMMATION; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN; OTALGIA; OTOTOXICITY; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PRESCHOOL CHILD; TREATMENT DURATION;

EID: 70449638756     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296434     Document Type: Article

References (33)

1. Grzegorowski M, Szydlowski J. [Acute otitis media in children]. Pol Merkuriusz Lek. 2005;19:494-496
2. Blomgren K, Pohjavuori S, Poussa T, Hatakka K, Korpela R, Pitkaranta A. Effect of accurate diagnostic criteria on incidence of acute otitis media in otitis-prone children. Scand J Infect Dis. 2004;36:6-9. (Pubitemid 38219763)
3. Garces-Sanchez M, Diez-Domingo J, Alvarez de Labiada T, Planelles V, Graullera M, Baldo JM, et al. [Epidemiology and burden of acute otitis media in Valencia (Spain)]. An Pediatr (Barc). 2004;60:125-132 (Pubitemid 38418572)
4. Ross AK, Croft PR, Collins M. Incidence of acute otitis media in infants in a general practice. J R Coll Gen Pract. 1988;38:70-72
5. Froom J, Culpepper L, Grob P, Bartelds A, Bowers P, Bridges-Webb C, et al. Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ. 1990;300:582-586 (Pubitemid 20090277)
6. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics. 2000;105:E72.
7. Taylor PS, Faeth I, Marks MK, Del Mar CB, Skull SA, Pezzullo ML, et al. Cost of treating otitis media in Australia. Expert Rev Pharmacoecon Outcomes Res. 2009;9:133-141
8. Federspil P, Federspil PA. [Antibiotic therapy in oto-rhinolaryngology]. HNO. 2005;53:11-28.
9. Federspil P. [Guidelines of the German society of oto-rhinolaryngology, head and neck surgery for the use of antibiotics in head and throat infections] 2008; AWMF-Leitlinien-Register Nr. 017/066.
10. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94. (Pubitemid 19162997)
11. Leibovitz E, Greenberg D. Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment. Chang Gung Med J. 2004;27:475-488 (Pubitemid 39215400)
12. Prasad S, Ewigman B. Use anesthetic drops to relieve acute otitis media pain. J Fam Pract. 2008;57:370-373 (Pubitemid 351842050)
13. Vogt WE. [Final report - Post-marketing surveillance study of Otalgan ear drops in children and adolescents]. Internal Report Study no. 021KLI98; Berlin: BiopharmGmbH; 1999.
14. Kraft K, Loew D, Schneider B, Kemper FH. [Planning, realization and evaluation of post-marketing surveillance studies. Recommendations of the Society for Phytotherapy]. Arzneimittelforschung. 1997;47:990-994
15. German Federal Institute for Drugs and Medical Devices (BfArM). [Guideline for the planning, conduct and evaluation of post-marketing surveillance studies]. 12 Nov 1998.
16. Rahlfs VW. clinical study report. Clinical study with local anesthetics and glycerol containing preparations for topical application in the ear. Gauting (Germany): idv Data Analysis and Study Planning; 2004;003KLI95:1.
17. Bolt P, Barnett P, Babl FE, Sharwood LN. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial. Arch Dis Child. 2008;93:40-44
18. Delb W, Federspil P. Hör-, Sprach- u. Stimmstörungen. In: Sitzmann FC, editor. Pädiatrie. 3rd ed. Stuttgart: Georg Thieme Verlag; 2007. p. 933-947.
19. Plasschaert AI, Rovers MM, Schilder AG, Verheij TJ, Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics. 2006;117:1879-1886
20. Johnson NC, Holger JS. Pediatric acute otitis media: the case for delayed antibiotic treatment. J Emerg Med. 2007;32:279-284 (Pubitemid 46467255)
21. AAP. American Academy of Pediatrics: The assessment and management of acute pain in infants, children, and adolescents. Pediatrics. 2001;108:793-797
22. CPS. Canadian Paediatric Society: Antibiotic Management of Acute Otitis Media, Index of Position Statements from the Infectious Diseases and Immunization Committee. Paediatr Child Health. 1998;3(4):265-267
23. Adam D. [Antibiotic therapy of ENT infections - How resistant are our pathogens?]. HNO-Nachrichten. 2004;5:28-32.
24. Koopman L, Hoes AW, Glasziou PP, Appelman CL, Burke P, McCormick DP, et al. Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media - a meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg. 2008;134:128-132 (Pubitemid 351287490)
25. Hyams JS, Feder H, Jr., Krause PJ, Frick J, McLaughlin JC, Furth T, Hine P. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. Pediatr Infect Dis. 1984;3:433-436
26. Cohen ML. Epidemiology of drug resistance - implications for a post-antimicrobial era. Science. 1992;257:1050-1055
27. Sanders S, Glasziou PP, Del Mar CB, Rovers M. Antibiotics for acute otitis media in children (Review). Cochrane Library, Issue 2, CD000219, pub. 2, 2009.
28. Granstrom G. ["Wait-and-see" in acute otitis media. An effective method for antibiotics use reduction - but a follow up is necessary]. Lakartidningen. 2006;103:3798.
29. Siegel RM, Kiely M, Bien JP, Joseph EC, Davis JB, Mendel SG, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics. 2003;112:527-531 (Pubitemid 37082101)
30. Marchetti F, Ronfani L, Nibali SC, Tamburlini G. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care. Arch Pediatr Adolesc Med. 2005;159:679-684 (Pubitemid 41003092)
31. Spiro DM, Arnold DH. The concept and practice of a wait-and-see approach to acute otitis media. Curr Opin Pediatr. 2008;20:72-78
32. Lacy SM. Writing a wait-and-see prescription for the treatment of acute otitis media may decrease the use of antibiotics. J Pediatr. 2007;150:319.
33. Shahroor S, Shvil Y, Ohali M, Granot E. [Acetaminophen toxicity in children as a "therapeutic misadventure"]. Harefuah. 2000;138:654-710.